| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.001 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |